No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Combined Modality Therapy
-
Cyclin D2
-
Cyclins / genetics*
-
Hematopoietic Stem Cell Transplantation*
-
Humans
-
Multiple Myeloma / drug therapy*
-
Multiple Myeloma / genetics*
-
Multiple Myeloma / mortality
-
Predictive Value of Tests
-
Prognosis
-
RNA, Messenger / genetics
-
Transplantation, Autologous
Substances
-
Antineoplastic Agents
-
CCND2 protein, human
-
Cyclin D2
-
Cyclins
-
RNA, Messenger